Skip to content

NAI Comments on Health Data Privacy RFI

On September 28, the NAI commented on Sen. Bill Cassidy’s (R-LA) Request for Information (RFI) on Improving Americans’ Health Data Privacy. The comments highlight three key recommendations: (1) Congress should emphasize the importance of data-driven health advertising for consumers and healthcare professionals, benefiting from improved access to medical treatments, discounts, and clinical trial viability. (2) Congress should pass a comprehensive consumer privacy law, focusing on preventing harmful outcomes and preventing broad limitations on access to health information, rather than expanding HIPAA’s scope. (3) A national privacy law should clearly define sensitive health information, distinguish non-sensitive and sensitive uses, and focus on all harmful uses of this information, regardless of sensitivity.

Similar Posts

Benefits of Tailored Advertising

March 26, 2021
Tailored advertising plays an integral role in driving economic growth and encouraging competition among companies. It affords small businesses and startups the ability to create new content and services. We’re
Read More